Machine learning for predicting high axillary nodal burden in breast cancer patients with positive sentinel lymph nodes.
Source check: Source checked. Not independent scientific confirmation.
Finding: Models using clinical and pathology features predicted high axillary nodal burden in sentinel-node-positive breast cancer; the retrospective cohort was split into training and validation sets, so prospective clinical utility remains unproven. The result is reported in the World Journal of Surgical Oncology. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: Nine machine-learning models were trained on clinicopathological features to predict high axillary nodal burden; LASSO and Boruta selected features, and SHAP interpreted the model.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Nine machine-learning models were trained on clinicopathological features to predict high axillary nodal burden; LASSO and Boruta selected features, and SHAP interpreted the model.
- Test and result
- Models using clinical and pathology features predicted high axillary nodal burden in sentinel-node-positive breast cancer; the retrospective cohort was split into training and validation sets, so prospective clinical utility remains unproven.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1186/s12957-026-04194-w · https://europepmc.org/article/MED/41742184 · https://europepmc.org/articles/PMC13041009 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC13041009/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.